Results 161 to 170 of about 3,403 (193)
Some of the next articles are maybe not open access.
Genitourinary syndrome of menopause: the unmet need
Menopause, 2021Abstract Genitourinary syndrome of menopause (GSM) is a highly prevalent and progressive condition of postmenopausal women that has significant negative effects on vulvovaginal health, sexual health, and overall quality of life. Despite many available safe and effective therapies, GSM often goes undiagnosed and untreated.
Susan Kellogg, Spadt, Lisa C, Larkin
openaire +2 more sources
Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis [PDF]
Maturitas, 2017 This study aimed to identify and then synthesize all available data regarding the efficacy of laser therapy for postmenopausal women with genitourinary syndrome of menopause (GSM) with/without urinary incontinence (UI).
Eleni Pitsouni +2 more
exaly +4 more sources
Genitourinary Syndrome of Menopause
Clinical Obstetrics & Gynecology, 2018Genitourinary syndrome of menopause (GSM) describes a collection of exam findings and bothersome symptoms associated with estrogen deficiency involving changes to the labia, introitus, clitoris, vagina, urethra, and bladder. Vulvovaginal atrophy is a component of GSM.
openaire +4 more sources
Genitourinary Syndrome of Menopause in Cancer Survivors
Clinical Obstetrics & Gynecology, 2023Genitourinary syndrome of menopause (GSM) encompasses the symptoms of estrogen deprivation in the vaginal, vulva, and bladder areas. Because many cancer treatments induce a hypoestrogenic state, GSM is common in cancer survivors. The number of cancer survivors is increasing, and the unique aspects of GSM management for cancer survivors, such as the ...
Catherine L, Dugan +2 more
openaire +2 more sources
Genitourinary Syndrome of Menopause: Prevalence and Predictors
Clinical Obstetrics & Gynecology, 2023The genitourinary syndrome of menopause (GSM) has been proposed as a diagnosis by a consensus of clinicians and investigators. Our purpose for this paper is to review extant evidence about: 1) the breadth of symptoms and symptom clusters as related to the syndrome; 2) the prevalence of GSM (includes vulvar and vaginal atrophy); 3) factors that are ...
NANCY F. WOODS +2 more
openaire +2 more sources
Laser Therapy for Genitourinary Syndrome of Menopause
Current Urology Reports, 2018The purpose of this article is to review the available data regarding the application and therapeutic outcomes of laser therapy for the treatment of genitourinary syndrome of menopause (GSM).There have been several studies regarding the use of laser therapy for the treatment of GSM. Most of these studies show a trend toward safe and effective treatment
Andrew, Rabley +4 more
openaire +2 more sources
A Dermatologist’s Approach to Genitourinary Syndrome of Menopause
Journal of Cutaneous Medicine and Surgery, 2017Background: Genitourinary syndrome of menopause (GSM) is a debilitating condition caused by hypoestrogenism that presents with vaginal dryness and dyspareunia as well as other genital, sexual, and urinary symptoms. Previously known as atrophic vaginitis, the term GSM is now used.
Matthew, Hum, Marlene, Dytoc
openaire +2 more sources
Genitourinary syndrome of menopause
The Nurse Practitioner, 2016Genitourinary syndrome of menopause (GSM) is the new name for the conditions that formerly included vulvovaginal atrophy and atrophic vaginitis. GSM better describes the range of conditions associated with low estrogen levels in menopause and invites patient discussion without the use of words that might be uncomfortable to say.
Katherine, Ward, Angela, Deneris
openaire +4 more sources
Diagnosis and Treatment of Genitourinary Syndrome of Menopause
Nursing for Women's Health, 2018Genitourinary syndrome of menopause (GSM), formerly referred to as vulvovaginal atrophy or atrophic vaginitis, is a common chronic condition that requires a collaborative treatment plan between a health care provider and a woman to relieve symptoms and improve quality of life.
Ashley L, Hodges +3 more
openaire +2 more sources
Androgens and genitourinary syndrome of the menopause
La Rivista Italiana di Ostetricia e Ginecologia, 2021Why androgens – testosterone and dehydroepiandrosterone (DHEA) – can play a role in the treatment of Genitourinary Syndrome of Menopause? What evidence supports this? Androgens are essential sex hormones for women’s health. Biological evidence (“bio-evidence”) indicates the following: androgens reach high plasma levels in childbearing age; have cell ...
openaire +1 more source